Amyloid peptide-induced cytokine and chemokine expression in THP-1 monocytes is blocked by small inhibitory RNA duplexes for early growth response-1 messenger RNA

Journal of Immunology

Volumn 170, Issue 10, 2003, Pages 5281-5294

  Giri, Ranjit K ^a   Selvaraj, Suresh K ^a   Kalra, Vijay K ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; CHEMOKINE; CYTOKINE; EARLY GROWTH RESPONSE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MONOCYTE CHEMOTACTIC PROTEIN 1; PEPTIDE; TRANSCRIPTION FACTOR AP 1;

ALZHEIMER DISEASE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CYTOKINE RELEASE; DNA BINDING; ENDOTHELIUM CELL; ENZYME ACTIVATION; GLIA CELL; HEMATOPOIETIC CELL; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; MESSENGER RNA SYNTHESIS; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR BLOCKING; STEM CELL; TARGET CELL;

EID: 0037883685     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.10.5281     Document Type: Article

References (64)

1. Wisniewski, T., J. Ghiso, and B. Frangione. 1997. Biology of Aβ amyloid in Alzheimer's disease. Neurobiol. Dis. 4:313.
2. Shoji, M., T. E. Golde, J. Ghiso, T. T. Cheung, S. Estus, L. M. Shaffer, X. D. Cai, D. M. McKay, R. Tintner, and B. Frangione. 1992. Production of the Alzheimer amyloid β protein by normal proteolytic processing. Science 258:126.
3. Mattson, M. P., and R. E. Rydel. 1996. Alzheimer's disease: amyloid ox-tox transducers. Nature 382:674.
4. Castano, E. M., and B. Frangione. 1991. Alzheimer's disease from the perspective of the systemic and localized forms of amyloidosis. Brain Pathol. 1:263.
5. Seubert, P., C. Vigo-Pelfrey, F. Esch, M. Lee, H. Dovey, D. Davis, S. Sinha, M. Schlossmacher, J. Whaley, and C. Swindlehurst. 1992. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359:325.
6. Robakis NK. 1994. β-Amyloid and amyloid precursor protein. Chemistry, molecular biology and neuropathology. In Alzheimer Disease. R. D. Terry, R. Katzman, and K. L. Bick, eds. Raven Press, New York, p. 317.
7. Mackic, J. B., M. H. Weiss, W. Miao, E. Kirkman, J. Ghiso, M. Calero, J. Bading, B. Frangione, and B. V. Zlokovic. 1998. Cerebrovascular accumulation and increased blood-brain barrier permeability to circulating Alzheimer's amyloid β peptide in aged squirrel monkey with cerebral amyloid angiopathy. J. Neurochem. 70:210.
8. Kuo, Y. M., M. R. Emmerling, H. C. Lampert, S. R. Hempelman, T. A. Kokjohn, A. S. Woods, R. J. Cotter, and A. E. Roher. 1999. High levels of circulating Aβ42 are sequestered by plasma proteins in Alzheimer's disease. Biochem. Biophys. Res. Commun. 257:787.
9. 125I-labeled β-amyloid peptide A β1-40 through the blood-brain barrier and binding to Alzheimer disease amyloid of the Aβ1-40/vector complex. Proc. Natl. Acad. Sci. USA 92:10227.
10. Maat-Schieman, M. L., S. G. van Duinen, A. J. Rozemuller, J. Haan, and R. A. Roos. 1997. Association of vascular amyloid β and cells of the mononuclear phagocyte system in hereditary cerebral hemorrhage with amyloidosis (Dutch) and Alzheimer disease. J. Neuropathol. Exp. Neurol. 56:273.
11. Uchihara, T., H. Akiyama, H. Kondo, and K. Ikeda. 1997. Activated microglial cells are colocalized with perivascular deposits of amyloid-β protein in Alzheimer's disease brain. Stroke 28:1948.
12. Yamada, M., Y. Itoh, M. Shintaku, J. Kawamura, O. Jensson, L. Thorsteinsson, N. Suematsu, M. Matsushita, and E. Otomo. 1996. Immune reactions associated with cerebral amyloid angiopathy. Stroke 27:1155.
13. Hickey, W. F., and H. Kimura. 1988. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239:290.
14. Eglitis, M. A., and E. Mezey. 1997. Hematopoietic cells differentiate into both microglia and macroglia in the brains of adult mice. Proc. Natl. Acad. Sci. USA 94:4080.
15. Thomas, T., E. T. Sutton, M. W. Bryant, and J. A. Rhodin. 1997. In vivo vascular damage, leukocyte activation and inflammatory response induced by β-amyloid. J. Submicrosc. Cytol. Pathol. 29:293.
16. Fiala, M., L. Zhang, X. Gan, B. Sherry, D. Taub, M. C. Graves, S. Hama, D. Way, M. Weinand, M. Witte, et al. 1998. Amyloid-β induces chemokine secretion and monocyte migration across a human blood-brain barrier model. Mol. Med. 4:480.
17. Giri, R., Y. Shen, M. Stins, Y. S. Du, A. M. Schmidt, D. Stern, K. S. Kim, B. Zlokovic, and V. K. Kalra. 2000. β-Amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am. J. Physiol. 279:C1772.
18. Combs, C. K., J. C. Karlo, S. C. Kao, and G. E. Landreth. 2001. β-Amyloid stimulation of microglia and monocytes results in TNFα-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21:1179.
19. Smits, H. A., A. J. van Beelen, N. M. de Vos, A. Rijsmus, B. T. van der, J. Verhoef, F. L. van Muiswinkel, and H. S. Nottet. 2001. Activation of human macrophages by amyloid-β is attenuated by astrocytes. J. Immunol. 166:6869.
20. Kienlen-Campard, P., S. Miolet, B. Tasiaux, and J. N. Octave. 2002. Intracellular amyloid-β 1-42, but not extracellular soluble amyloid-β peptides, induces neuronal apoptosis. J. Biol. Chem. 277:15666.
21. Akama, K. T., and L. J. Van Eldik. 2000. β-Amyloid sfimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1β- and tumor necrosis factor-α (TNFα)-dependent, and involves a TNFα receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism. J. Biol. Chem. 275:7918.
22. Yan, S. D., X. Chen, J. Fu, M. Chen, H. Zhu, A. Roher, T. Slattery, L. Zhao, M. Nagashima, J. Morser, et al. 1996. RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease. Nature 382:685.
23. Combs, C. K., D. E. Johnson, J. C. Karlo, S. B. Cannady, and G. E. Landreth. 2000. Inflammatory mechanisms in Alzheimer's disease: inhibition of β-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARγ agonists. J. Neurosci. 20:558.
24. Akiyama, H., S. Barger, S. Barnum, B. Bradt, J. Bauer, G. M. Cole, N. R. Cooper, P. Eikelenboom, M. Emmerling, B. L. Fiebich, et al. 2000. Inflammation and Alzheimer's disease. Neurobiol. Aging 21:383.
25. Mackenzie, I. R. 1996. Antiinflammatory drugs in the treatment of Alzheimer's disease. J. Rheumatol. 23:806.
26. Giri, R., S. Selvaraj, C. A. Miller, F. Hofman, S. D. Yan, D. Stern, B. V. Zlokovic, and V. K. Kalra. 2002. Effect of endothelial cell polarity on β-amyloid-induced migration of monocytes across normal and AD endothelium. Am. J. Physiol. 283:C895.
27. Mackic, J. B., M. Stins, J. G. McComb, M. Calero, J. Ghiso, K. S. Kim, S. D. Yan, D. Stern, A. M. Schmidt, B. Frangione, et al. 1998. Human blood-brain barrier receptors for Alzheimer's amyloid-β 1-40: asymmetrical binding, endocytosis, and transcytosis at the apical side of brain microvascular endothelial cell monolayer. J. Clin. Invest. 102:734.
28. Yates, S. L., L. H. Burgess, J. Kocsis-Angle, J. M. Antal, M. D. Dority, P. B. Embury, A. M. Piotrkowski, and K. R. Brunden. 2000. Amyloid β and amylin fibrils induce increases in proinflammatory cytokine and chemokine production by THP-1 cells and murine microglia. J. Neurochem. 74:1017.
29. Lopez, D. L. P., K. Goldie, J. Zurdo, E. Lacroix, C. M. Dobson, A. Hoenger, and L. Serrano. 2002. De novo designed peptide-based amyloid fibrils. Proc. Natl. Acad. Sci. USA 99:16052.
30. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
31. Elbashir, S. M., W. Lendeckel, and T. Tuschl. 2001. RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev. 15:188.
32. Abdelrahim, M., I. Samudio, R. Smith, III, R. Burghardt, and S. Safe. 2002. Small inhibitory RNA duplexes for Sp1 mRNA block basal and estrogen-induced gene expression and cell cycle progression in MCF-7 breast cancer cells. J. Biol. Chem. 277:28815.
33. Szczepanik, A. M., D. Rampe, and G. E. Ringheim. 2001. Amyloid-β peptide fragments p3 and p4 induce pro-inflammatory cytokine and chemokine production in vitro and in vivo. J. Neurochem. 77:304.
34. Meda, L., P. Baron, E. Prat, E. Scarpini, G. Scarlato, M. A. Cassatella, and F. Rossi. 1999. Proinflammatory profile of cytokine production by human monocytes and murine microglia stimulated with β-amyloid[25-35]. J. Neuroimmunol. 93:45.
35. Linassier, C., M. Pierre, J. B. Le Pecq, and J. Pierre. 1990. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity. Biochem. Pharmacol. 39:187.
36. Dudley, D. T., L. Pang, S. J. Decker, A. J. Bridges, and A. R. Saltiel. 1995. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc. Natl. Acad. Sci. USA 92:7686.
37. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95.
38. Bennett, B. L., D. T. Sasaki, B. W. Murray, E. C. O'Leary, S. T. Sakata, W. Xu, J. C. Leisten, A. Motiwala, S. Pierce, Y. Satoh, et al. 2001. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 98:13681.
39. Favata, M. F., K. Y. Horiuchi, E. J. Manos, A. J. Daulerio, D. A. Stradley, W. S. Feeser, D. E. Van Dyk, W. J. Pitts, R. A. Earl, F. Hobbs, et al. 1998. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273:18623.
40. Lackey, K., M. Cory, R. Davis, S. V. Frye, P. A. Harris, R. N. Hunter, D. K. Jung, O. B. McDonald, R. W. McNutt, M. R. Peel, et al. 2000. The discovery of potent craf1 kinase inhibitors. Bioorg. Med. Chem. Lett. 10:223.
41. McDonald, D. R., M. E. Bamberger, C. K. Combs, and G. E. Landreth. 1998. β-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes. J. Neurosci. 18:4451.
42. Aplin, A. E., S. A. Stewart, R. K. Assoian, and R. L. Juliano. 2001. Integrin-mediated adhesion regulates ERK nuclear translocation and phosphorylation of Elk-1. J. Cell Biol. 153:273.
43. Guha, M., M. A. O'Connell, R. Pawlinski, A. Hollis, P. McGovern, S. F. Yan, D. Stem, and N. Mackman. 2001. Lipopolysaccharide activation of the MEK-ERK1/2 pathway in human monocytic cells mediates tissue factor and tumor necrosis factor a expression by inducing Elk-1 phosphorylation and Egr-1 expression. Blood 98:1429.
44. Xu, Z., R. Dziarski, Q. Wang, K. Swartz, K. M. Sakamoto, and D. Gupta. 2001. Bacterial peptidoglycan-induced TNF-α transcription is mediated through the transcription factors Egr-1, Elk-1, and NF-κB. J. Immunol. 167:6975.
45. Yan, S. F., T. Fujita, J. Lu, K. Okada, Z. Y. Shan, N. Mackman, D. J. Pinsky, and D. M. Stern. 2000. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat. Med. 6:1355.
46. Silverman, E. S., and T. Collins. 1999. Pathways of Egr-1-mediated gene transcription in vascular biology. Am. J. Pathol. 154:665.
47. Yan, S. D., H. Zhu, J. Fu, S. F. Yan, A. Roher, W. W. Tourtellotte, T. Rajavashisth, X. Chen, G. C. Godman, D. Stern, et al. 1997. Amyloid-β peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc. Natl. Acad. Sci. USA 94:5296.
48. Murphy, G. M., Jr., L. Yang, and B. Cordell. 1998. Macrophage colony-stimulating factor augments β-amyloid-induced interleukin-1, interleukin-6, and nitric oxide production by microglial cells. J. Biol. Chem. 273:20967.
49. Wei, W., X. Wang, and J. W. Kusiak. 2002. Signaling events in amyloid β-peptide-induced neuronal death and insulin-like growth factor I protection. J. Biol. Chem. 277:17649.
50. Ma, W., W. Lim, K. Gee, S. Aucoin, D. Nandan, M. Kozlowski, F. Diaz-Mitoma, and A. Kumar. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276:13664.
51. el Khoury, J., S. E. Hickman, C. A. Thomas, L. Cao, S. C. Silverstein, and J. D. Loike. 1996. Scavenger receptor-mediated adhesion of microglia to β-amytoid fibrils. Nature 382:716.
52. Yao, J., N. Mackman, T. S. Edgington, and S. T. Fan. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells: regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272: 17795.
53. Tsai, E. Y., J. V. Falvo, A. V. Tsytsykova, A. K. Barczak, A. M. Reimold, L. H. Glimcher, M. J. Fenton, D. C. Gordon, I. F. Dunn, and A. E. Goldfeld. 2000. A lipopolysaccharide-specific enhancer complex involving Ets, Elk-1, Sp1, and CREB binding protein and p300 is recruited to the tumor necrosis factor α promoter in vivo. Mol. Cell. Biol. 20:6084.
54. Finzer, P., U. Soto, H. Delius, A. Patzelt, J. F. Coy, A. Poustka, H. H. zur, and F. Rosl. 2000. Differential transcriptional regulation of the monocyte-chemoattractant protein-1 (MCP-1) gene in tumorigenic and non-tumorigenic HPV 18 positive cells: the role of the chromatin structure and AP-1 composition. Oncogene 19:3235.
55. Schreck, R., P. Rieber, and P. A. Baeuerle. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247.
56. Bianca, V. D., S. Dusi, E. Bianchini, P. Dal, I, and F. Rossi. 1999. β-Amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils: a possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J. Biol. Chem. 274:15493.
57. Sui, G., C. Soohoo, e. B. Affar, F. Gay, Y. Shi, W. C. Forrester, and Y. Shi. 2002. A DNA vector-based RNAi technology to suppress gene expression in mammalian cells. Proc. Natl. Acad. Sci. USA 99:5515.
58. Okada, M., T. Fujita, T. Sakaguchi, K. E. Olson, T. Collins, D. M. Stern, S. F. Yan, and D. J. Pinsky. 2001. Extinguishing Egr-1-dependent inflammatory and thrombotic cascades after lung transplantation. FASEB J. 15:2757.
59. Srivastava, S., M. N. Weitzmann, R. B. Kimble, M. Rizzo, M. Zahner, J. Milbrandt, F. P. Ross, and R. Pacifici. 1998. Estrogen blocks M-CSF gene expression and osteoclast formation by regulating phosphorylation of Egr-1 and its interaction with Sp-1. J. Clin. Invest 102:1850.
60. Hoffmann, E., O. Dittrich-Breiholz, H. Holtmann, and M. Kracht. 2002. Multiple control of interleukin-8 gene expression. J. Leukocyte Biol. 72:847.
61. Hipp, M. S., C. Urbich, P. Mayer, J. Wischhusen, M. Weller, M. Kracht, and L. Spyridopoulos. 2002. Proteasome inhibition leads to NF-κB-independent IL-8 transactivation in human endothelial cells through induction of AP-1. Eur. J. Immunol. 32:2208.
62. Levkovitz, Y., and J. M. Baraban. 2002. A dominant negative Egr inhibitor blocks nerve growth factor-induced neurite outgrowth by suppressing c-Jun activation: role of an Egr/c-Jun complex. J. Neurosci. 22:3845.
63. Levkovitz, Y., and J. M. Baraban, 2001. A dominant negative inhibitor of the Egr family of transcription regulatory factors suppresses cerebellar granule cell apoptosis by blocking c-Jun activation, J. Neurosci. 21:5893.
64. Bavendiek, U., P. Libby, M. Kilbride, R. Reynolds, N. Mackman, and U. Schonbeck. 2002. Induction of tissue factor expression in human endothelial cells by CD40 ligand is mediated via activator protein 1, nuclear factor κB, and Egr-1. J. Biol. Chem. 277:25032.